Literature DB >> 29943140

Laparoscopic Heller Myotomy and Hiatal Hernia Repair After Failed Peroral Endoscopic Myotomy.

Christopher G Yheulon1, Paul B Brock2, Fadi M Balla2, Jamil L Stetler2, Edward Lin2.   

Abstract

Entities:  

Keywords:  Achalasia; Heller myotomy; Hiatal hernia; Intraoperative endoscopy; Laparoscopic; Peroral endoscopic myotomy; Recurrent achalasia

Year:  2018        PMID： 29943140     DOI： 10.1007/s11605-018-3847-1

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  3 in total

1.  Efficacy and Safety of Peroral Endoscopic Myotomy for Treatment of Achalasia After Failed Heller Myotomy.

Authors:  Saowanee Ngamruengphong; Haruhiro Inoue; Michael B Ujiki; Lava Y Patel; Amol Bapaye; Pankaj N Desai; Shivangi Dorwat; Jun Nakamura; Yoshitaka Hata; Valerio Balassone; Manabu Onimaru; Thierry Ponchon; Mathieu Pioche; Sabine Roman; Jérôme Rivory; François Mion; Aurélien Garros; Peter V Draganov; Yaseen Perbtani; Ali Abbas; Davinderbir Pannu; Dennis Yang; Silvana Perretta; John Romanelli; David Desilets; Bu Hayee; Amyn Haji; Gulara Hajiyeva; Amr Ismail; Yen-I Chen; Majidah Bukhari; Yamile Haito-Chavez; Vivek Kumbhari; Payal Saxena; Michael Talbot; Philip Wai-Yan Chiu; Hon-Chi Yip; Vivien Wai-Yin Wong; Ruben Hernaez; Roberta Maselli; Alessandro Repici; Mouen A Khashab
Journal:  Clin Gastroenterol Hepatol       Date:  2017-02-09       Impact factor: 11.382

2.  Management of recurrent symptoms after per-oral endoscopic myotomy in achalasia.

Authors:  Froukje B van Hoeij; Fraukje A Ponds; Yuki Werner; Joel M Sternbach; Paul Fockens; Barbara A Bastiaansen; André J P M Smout; John E Pandolfino; Thomas Rösch; Albert J Bredenoord
Journal:  Gastrointest Endosc       Date:  2017-05-03       Impact factor: 9.427

3.  [Surgical treatment of achalasia - endoscopic or laparoscopic? : Proposal for a tailored approach].

Authors:  B H A von Rahden; J Filser; M Al-Nasser; C-T Germer
Journal:  Chirurg       Date:  2017-03       Impact factor: 0.955
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.